Innovating Works

ISMETT

Desconocido
PROTECT-CHILD: A PRivacy prOTecting Environment for Child Transplants health related and genomic data integration i... PROTECT-CHILD is a project that aims to improve the outcomes of rare pediatric transplant patients by integrating multiple sources of high-t...
2024-06-30 - 2028-12-31 | Financiado
BIOMITRAL: Engineering the mitral valve bioinspired control of structure and function for enhanced in vivo per... ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE SRL ISMETT SRL participó en un H2020: ERC-2020-COG Tissue Engineered Heart Valves (TEHVs) can restore function in the pulmonary and aortic positions and have shown capacity for tissue regener...
2021-07-16 - 2026-08-31 | Financiado
SimInSitu: In silico Development and Clinical Trial Platform for Testing in situ Tissue Engineered Heart Valve... ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE SRL ISMETT SRL participó en un H2020: H2020-SC1-DTH-2018-2020 SimInSitu is aiming to develop a sophisticated in-silico method to predict the short- and long-term behavior of in-situ tissue engineered he...
2020-12-03 - 2024-12-31 | Financiado
NEXT: Nano Engineering for Cross Tolerance new approach for bioengineered vascularised chimeric islet t... ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE SRL ISMETT SRL participó en un FP7: Diabetes is caused by insufficient or lack of insulin secretion by the specialized B cells of the pancreas and, if not treated adequately ev...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.